The need to establish a common base line for the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets

Iranian Journal of Pharmaceutical Research

Volumn 7, Issue 4, 2008, Pages 233-235

  Pourahmad, Jalal ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; DICLOFENAC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG MARKETING; DRUG SAFETY; DRUG SCREENING; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; LIVER DISEASE; LIVER TOXICITY; MAXIMUM PLASMA CONCENTRATION; MORTALITY; NEUTROPENIA; PRESCRIPTION; RISK BENEFIT ANALYSIS;

EID: 67549090416     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Fung, M. Thornton, A., Mybeck, K., Hsiao-Hui, W., Hornbuckle K., Muniz E., Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-160-1999, Drug Information J. (2001) 35, 293-317
2. Smith, D.A., Schmid, E.F., Drug withdrawals and the lessons within. Current Opinion in Drug Discovery and Development (2006) 9, 38-46.
3. Hussaini S.H., Farrington, E.A., Idiosyncratic drug-induced liver injury: an overview. Expert Opinion Drug Safety (2007) 6, 673-684
4. Traversa G., Bianchi C., DaCas R., Abraha I., Menniti-Ippolito F., Venegoni M., Cohort study of hepatotoxicity associated with nimesulide and other nonsteroidal anti-imflammatory drugs, B.M.J. (2003) 327, 18-22
5. O'Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., Brain, P., Hougham, C. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Archives of Toxicology (2006) 80, 580-604
6. Lazarou, J., Pomeranz, B.H., and Corey, P.N., Incidence of adverse drug reactions in hospitalised patients. JAMA (1998) 279, 1200-1205.
7. Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A.K., Walley, T.J., Farrar, K., Park, K.B., Breckenridge, A.M. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ (2004) 329, 15-19
8. Juntti-Patinen, L., Neuvonen, P. J., Drug -related deaths in a university central hospital, European Journal of Clinical Pharmacology (2002) 58, 479-482
9. Hawkins, L. C., Edwards, John N., Dargan, P. I., Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom a review of the literature. Drug Safety (2007), 30, 465-479